The GliomaEd.com advisory board comprises renowned academic and clinical leaders in the fields of radiation oncology, neuro-oncology, and neurosurgery. The following advisory board members contribute and review content for GliomaEd.com:

Arnab Chakravarti, MD, Chair and Professor, Department of Radiation Oncology, Ohio State University Medical School, Columbus, OH

Marc C. Chamberlain, MD, Professor, Department of Neurology and Neurosurgery, University of Washington, Seattle, WA

Matthew G. Ewend, MD, Associate Professor and Chief, Division of Neurosurgery, University of North Carolina at Chapel Hill, Chapel Hill, NC

Mark R. Gilbert, MD, Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Andrew B. Lassman, MD, Assistant Professor of Neurology, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY

William F. Regine, MD, Professor and Chair, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD

Timothy C. Ryken, MD, MS, Associate Professor, Department of Neurosurgery, University of Iowa College of Medicine, Iowa City, IA

Volker W. Stieber, MD, Assistant Professor, Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC

Disclosure Statements

Dr. Chakravarti discloses that he serves on the speakers’ bureau of Schering-Plough and is a consultant for Genentech.

Dr. Chamberlain discloses that he serves on the speakers’ bureaus of Genentech and Schering-Plough and is a consultant for Genentech and Schering-Plough.

Dr. Ewend discloses receipt of research support from Eisai Pharmaceuticals.

Dr. Gilbert discloses that he serves on the speakers’ bureau of Schering-Plough and is a consultant for Genentech, Pfizer, and Schering-Plough. He has also received research support from Genentech and Schering-Plough.

Dr. Lassman discloses that he serves on the speakers’ bureau of Schering-Plough and is a consultant for Bristol-Myers Squibb, Cephalon, Eisai, Genentech, and Imclone. He has also received research support from AstraZeneca, Keryx, and Sigma Tau.

Dr. Regine discloses no actual or potential conflict of interest

Dr. Ryken discloses that he serves on the speakers’ bureaus of Eisai and Schering-Plough and is a consultant for Medtronic. He has also received research support from Eisai and Medtronic.

Dr. Stieber discloses that he serves on advisory committees for Cytyc Corporation and Monteris Medical.